Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
Sweden
In shortAsker Healthcare Group AB is profitable, generates cash and carries moderate debt, with revenue growing (+11.7% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 6.0% | 37/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 2.9% | 32/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 9.8% | 49/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 6.9% | 46/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.36× | 46/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.73× | 71/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 3.86× | 4/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.76× | 3/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.06 | 25/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 7.9% | 52/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 2.70× | 100/100 |
| Years with positive free cash flow (last 5) | 2 of 2 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 2 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 1 | 100/100 |
| Revenue growth volatility | – | n/a |
| Operating margin volatility | 0.3% | 100/100 |
Weight in the score: 20%
Fiscal year 2025 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
The same model applied each year to the statements published at the time: the score is never recalculated with later information.
The last 2 fiscal years from the company's annual reports.
SEK millions; negative values in parentheses.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Revenue | 15,025 | 16,787 |
| Cost of revenue | 9,147 | 9,916 |
| Gross profit | 5,879 | 6,871 |
| Operating income | 966 | 1,009 |
| Interest expense | 517 | 572 |
| Pre-tax income | 559 | 659 |
| Income tax | 183 | 149 |
| Net income | 360 | 492 |
| Diluted EPS | kr0.74 | kr1.25 |
2.06 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Apr 16, 2026